New Products: Titan Spine Earns 510(k) For Lateral Fusion Device; Data On Misonix’ Ultrasonic BoneScalpel Published; Boston Scientific Earns CE Mark For Midsized TAVR
This article was originally published in The Gray Sheet
Executive Summary
Titan boasts its Endoskeleton TL is the first lateral spine fusion device to feature surface technology. New trial data shows surgical correction of adolescent idiopathic scoliosis with the ultrasonic BoneScalpel reduces blood-loss. Boston Scientific set to launch 25 mm version of Lotus transcatheter aortic valve in Europe to compliment 23 mm and 27 mm sizes.
You may also be interested in...
TAVR Evolution On Display At EuroPCR
Data on both new transcatheter aortic valve technologies and established TAVR devices were featured at this year’s EuroPCR meeting in Paris.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.